ASTM F2312 Standard Terminology Relating to Tissue Engineered Medical Products
Данный раздел/документ содержится в продуктах:
- Техэксперт: Машиностроительный комплекс
- Картотека зарубежных и международных стандартов
- ASTM F3106 Standard Guide for in vitro Osteoblast Differentiation Assays
- ASTM F2997 Standard Practice for Quantification of Calcium Deposits in Osteogenic Culture of Progenitor Cells Using Fluorescent Image Analysis
- ASTM F2997 Standard Practice for Quantification of Calcium Deposits in Osteogenic Culture of Progenitor Cells Using Fluorescent Image Analysis
- ASTM F2900 Standard Guide for Characterization of Hydrogels used in Regenerative Medicine
- ASTM F2739 Standard Guide for Quantitating Cell Viability Within Biomaterial Scaffolds
- ASTM F2315 Standard Guide for Immobilization or Encapsulation of Living Cells or Tissue in Alginate Gels
- ASTM F2315 Standard Guide for Immobilization or Encapsulation of Living Cells or Tissue in Alginate Gels
- ASTM F2739 Standard Guide for Quantitating Cell Viability Within Biomaterial Scaffolds
- ASTM F3163 Standard Guide for Classification of Cellular and/or Tissue-Based Products (CTPs) for Skin Wounds
- ASTM F2312 Standard Terminology Relating to Tissue Engineered Medical Products
- ASTM F2664 Standard Guide for Assessing the Attachment of Cells to Biomaterial Surfaces by Physical Methods
- ASTM F2791 Standard Guide for Assessment of Surface Texture of Non-Porous Biomaterials in Two Dimensions
- ASTM F3106 Standard Guide for in vitro Osteoblast Differentiation Assays
- Картотека зарубежных и международных стандартов
ASTM International
Standard Terminology Relating to Tissue Engineered Medical Products
N F2312
Annotation
This terminology defines basic terms and presents the relationships of the scientific fields related to Tissue Engineered Medical Products (TEMPs). Committee F04 has defined these terms for the specific purpose of unifying the language used in standards for TEMPs.
The terms and relationships defined here are limited to TEMPs. They do not apply to any medical products of human origin regulated by the U.S. Food and Drug Administration under 21 CFR Parts 16 and 1270 and 21 CFR Parts 207, 807, and 1271.
The terms and nomenclature presented in this standard are for the specific purposes of unifying the language used in TEMP standards and are not intended for labeling of regulated medical products.
This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
Автоматический перевод:
Стандартная терминология, касающаяся ткани спроектированные лекарственные препараты
Эта терминология определяет основные условия и представляет отношения научных полей, связанных с Тканью Спроектированные Лекарственные препараты (ВРЕМЕННЫЕ ФАЙЛЫ). Комитет F04 определил эти условия для определенной цели объединить язык, используемый в стандартах для ВРЕМЕННЫХ ФАЙЛОВ.
